Lee Lim Phones & Addresses
-
Fremont, CA
-
Cupertino, CA
-
San Jose, CA
-
San Antonio, TX
Resumes
Resumes
Lee Lim
View pageWork:
Compass Group North America Jun 2005 - Jun 2009
Director of Dining Services
Compass Group North America Jun 2003 - Aug 2005
Associate Director of Dining Services
Compass Group North America Sep 2001 - Jun 2003
Service Manager
Director of Dining Services
Compass Group North America Jun 2003 - Aug 2005
Associate Director of Dining Services
Compass Group North America Sep 2001 - Jun 2003
Service Manager
Education:
University of Arkansas at Fayetteville 1998 - 2001
B.S.B.A., Small Business and Entrepreneurship Management
B.S.B.A., Small Business and Entrepreneurship Management
Human Resources Specialist
View pageWork:
Hsbc
Human Resources Specialist
Human Resources Specialist
Lee Lim
View page
Lee Lim
View page
Lee Lim
View pageLocation:
United States
Lee Lim
View pageLocation:
United States
Lee Lim
View pageLocation:
United States
Lee Lim
View pageLocation:
United States
Publications
Us Patents
Single-Stranded Rnai Agents Containing An Internal, Non-Nucleic Acid Spacer
View pageUS Patent:
20130171242, Jul 4, 2013
Filed:
Aug 19, 2011
Appl. No.:
13/818306
Inventors:
Lee Lim - San Francisco CA, US
Guillaume Chorn - Sheung Wan, HK
Aarron Willingham - Mountain View CA, US
Lihong Zhao - Walnut Creek CA, US
Guillaume Chorn - Sheung Wan, HK
Aarron Willingham - Mountain View CA, US
Lihong Zhao - Walnut Creek CA, US
International Classification:
C12N 15/113
US Classification:
424450, 536 245, 514 44 A, 435375, 424400
Abstract:
Single-stranded RNA molecules comprise one or more internal, non-nucleotide spacers, covalently linked with nucleotide portions of the molecule are provided. The single-stranded RNA molecules function as guide or antisense strands that are capable of inhibiting gene expression via an RNA interference mechanism, and thus represent single-stranded RNAi agents. The single-stranded RNAi molecules can be used in methods for a variety of therapeutic, diagnostic, target validation, genomic discovery, genetic engineering, and pharmacogenomic applications.
Segmented Micro Rna Mimetics
View pageUS Patent:
20130225652, Aug 29, 2013
Filed:
Aug 24, 2010
Appl. No.:
13/391703
Inventors:
Guillaume Chorn - San Francisco CA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
International Classification:
C12N 15/113
US Classification:
514 44 A, 536 245
Abstract:
This invention relates generally to segmented oligonucleotides capable of modulating gene expression. Specifically, the instant invention relates to segmented microRNA (miRNA) oligonucleotides, including segmented miRNA precursors and segmented pre-microRNAs. The invention also relates to compositions comprising such segmented oligonucleotides, as well as to methods of making and using such oligonucleotides for diagnosis and treatment of diseases associated or causally linked to aberrant levels or activities of gene expression, including aberrant levels of coding and/or non-coding RNA.
Segmented Micro Rna Mimetics
View pageUS Patent:
20180112216, Apr 26, 2018
Filed:
Jul 12, 2017
Appl. No.:
15/648288
Inventors:
- Cambridge MA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
International Classification:
C12N 15/113
C12N 15/11
C12N 15/11
Abstract:
This invention relates generally to segmented oligonucleotides capable of modulating gene expression. Specifically, the instant invention relates to segmented microRNA (miRNA) oligonucleotides, including segmented miRNA precursors and segmented pre-microRNAs. The invention also relates to compositions comprising such segmented oligonucleotides, as well as to methods of making and using such oligonucleotides for diagnosis and treatment of diseases associated or causally linked to aberrant levels or activities of gene expression, including aberrant levels of coding and/or non-coding RNA.
Segmented Micro Rna Mimetics
View pageUS Patent:
20150376613, Dec 31, 2015
Filed:
Jun 23, 2015
Appl. No.:
14/747264
Inventors:
- Cambridge MA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
Lee Lim - San Francisco CA, US
Lihong Zhao - Walnut Creek CA, US
Assignee:
SIRNA THERAPEUTICS, INC. - Cambridge MA
International Classification:
C12N 15/113
Abstract:
This invention relates generally to segmented oligonucleotides capable of modulating gene expression. Specifically, the instant invention relates to segmented microRNA (miRNA) oligonucleotides, including segmented miRNA precursors and segmented pre-microRNAs. The invention also relates to compositions comprising such segmented oligonucleotides, as well as to methods of making and using such oligonucleotides for diagnosis and treatment of diseases associated or causally linked to aberrant levels or activities of gene expression, including aberrant levels of coding and/or non-coding RNA.